Sarah E. Ernst

2.1k total citations
34 papers, 1.3k citations indexed

About

Sarah E. Ernst is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Sarah E. Ernst has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Sarah E. Ernst's work include Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (5 papers). Sarah E. Ernst is often cited by papers focused on Cystic Fibrosis Research Advances (14 papers), Neonatal Respiratory Health Research (10 papers) and Tracheal and airway disorders (5 papers). Sarah E. Ernst collaborates with scholars based in United States, Canada and Colombia. Sarah E. Ernst's co-authors include Philip H. Karp, Michael J. Welsh, Joseph Zabner, David A. Stoltz, Leah R. Reznikov, Alejandro A. Pezzulo, Karen S. Sfanos, Xiao Xiao Tang, Lynda S. Ostedgaard and Thomas O. Moninger and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Sarah E. Ernst

32 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah E. Ernst United States 19 744 451 133 131 116 34 1.3k
S. Heyder Germany 7 908 1.2× 519 1.2× 149 1.1× 88 0.7× 127 1.1× 10 1.4k
Vanya Icheva Germany 7 834 1.1× 497 1.1× 124 0.9× 101 0.8× 181 1.6× 17 1.5k
M. Leslie Fulcher United States 10 837 1.1× 345 0.8× 161 1.2× 116 0.9× 67 0.6× 10 1.3k
Kimberlie A. Burns United States 15 764 1.0× 680 1.5× 132 1.0× 164 1.3× 127 1.1× 22 1.6k
Torry A. Tucker United States 21 549 0.7× 280 0.6× 62 0.5× 134 1.0× 58 0.5× 61 1.0k
Marc Merten France 22 391 0.5× 489 1.1× 107 0.8× 72 0.5× 159 1.4× 48 1.1k
Anabela S. Ramalho Belgium 19 701 0.9× 427 0.9× 76 0.6× 66 0.5× 188 1.6× 39 1.2k
Martin Stern United Kingdom 10 882 1.2× 484 1.1× 342 2.6× 85 0.6× 127 1.1× 16 1.6k
M J Yezzi United States 8 495 0.7× 524 1.2× 149 1.1× 45 0.3× 116 1.0× 12 1.2k
Lesley J. MacVinish United Kingdom 12 542 0.7× 469 1.0× 94 0.7× 68 0.5× 165 1.4× 13 1.0k

Countries citing papers authored by Sarah E. Ernst

Since Specialization
Citations

This map shows the geographic impact of Sarah E. Ernst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Ernst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Ernst more than expected).

Fields of papers citing papers by Sarah E. Ernst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Ernst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Ernst. The network helps show where Sarah E. Ernst may publish in the future.

Co-authorship network of co-authors of Sarah E. Ernst

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah E. Ernst. A scholar is included among the top collaborators of Sarah E. Ernst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah E. Ernst. Sarah E. Ernst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schultz, Jordan L., Phillip E. Gander, Craig D. Workman, et al.. (2025). A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults. Journal of Parkinson s Disease. 15(7). 1253–1263.
2.
3.
Mekkawy, Aml I., Youssef W. Naguib, Jeong‐Ah Kim, et al.. (2023). Injectable long-acting ivacaftor-loaded poly (lactide-co-glycolide) microparticle formulations for the treatment of cystic fibrosis: In vitro characterization and in vivo pharmacokinetics in mice. International Journal of Pharmaceutics. 650. 123693–123693. 5 indexed citations
4.
White, James R., et al.. (2022). Incorporation of Data From Multiple Hypervariable Regions when Analyzing Bacterial 16S rRNA Gene Sequencing Data. Frontiers in Genetics. 13. 799615–799615. 16 indexed citations
6.
Vidal, Igor, Qizhi Zheng, Jessica Hicks, et al.. (2021). GSTP1 positive prostatic adenocarcinomas are more common in Black than White men in the United States. PLoS ONE. 16(6). e0241934–e0241934. 10 indexed citations
7.
Shrestha, Eva, Jonathan B. Coulter, Sarah E. Ernst, et al.. (2021). Oncogenic gene fusions in nonneoplastic precursors as evidence that bacterial infection can initiate prostate cancer. Proceedings of the National Academy of Sciences. 118(32). 32 indexed citations
8.
Schultz, Jordan L., Jia Xu, Sarah E. Ernst, et al.. (2021). A pilot to assess target engagement of terazosin in Parkinson's disease. Parkinsonism & Related Disorders. 94. 79–83. 28 indexed citations
9.
Liu, Wennuan, Shun Zheng, Rong Na, et al.. (2020). Distinct Genomic Alterations in Prostate Tumors Derived from African American Men. Molecular Cancer Research. 18(12). 1815–1824. 18 indexed citations
10.
Sfanos, Karen S., Mark C. Markowski, Lauren B. Peiffer, et al.. (2018). Compositional differences in gastrointestinal microbiota in prostate cancer patients treated with androgen axis-targeted therapies. Prostate Cancer and Prostatic Diseases. 21(4). 539–548. 104 indexed citations
11.
Meyerholz, David K., David A. Stoltz, Sarah E. Ernst, et al.. (2018). Lack of cystic fibrosis transmembrane conductance regulator disrupts fetal airway development in pigs. Laboratory Investigation. 98(6). 825–838. 28 indexed citations
12.
Shah, Viral S., David K. Meyerholz, Xiao Xiao Tang, et al.. (2016). Airway acidification initiates host defense abnormalities in cystic fibrosis mice. Science. 351(6272). 503–507. 223 indexed citations
14.
Wallen, Tanner J., Philip H. Karp, Sarah E. Ernst, et al.. (2013). Adenoviral Gene Transfer Corrects the Ion Transport Defect in the Sinus Epithelia of a Porcine CF Model. Molecular Therapy. 21(5). 947–953. 21 indexed citations
15.
Ernst, Sarah E. & Andrew Edwards. (2013). REDUCING RISK AND PROMOTING SUSTAINABILITY IN THE FOOTHILLS OF THE HIMALAYAS A Pedagogy for Teaching and Practicing Sustainable Development. International Journal of Architectural Research: Archnet-IJAR. 7(3). 93–107. 3 indexed citations
16.
Clancy, John, Rhonda D. Szczesniak, Melissa A. Ashlock, et al.. (2013). Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function. PLoS ONE. 8(9). e73905–e73905. 47 indexed citations
17.
Li, Xiaopeng, Nathan D. Rossen, Patrick L. Sinn, et al.. (2013). Integrin α6β4 Identifies Human Distal Lung Epithelial Progenitor Cells with Potential as a Cell-Based Therapy for Cystic Fibrosis Lung Disease. PLoS ONE. 8(12). e83624–e83624. 14 indexed citations
18.
Chang, Eugene H., Alejandro A. Pezzulo, David K. Meyerholz, et al.. (2012). Sinus hypoplasia precedes sinus infection in a porcine model of cystic fibrosis. The Laryngoscope. 122(9). 1898–1905. 53 indexed citations
19.
Pezzulo, Alejandro A., Peter J. Taft, Sarah E. Ernst, et al.. (2011). Glucose Depletion in the Airway Surface Liquid Is Essential for Sterility of the Airways. PLoS ONE. 6(1). e16166–e16166. 98 indexed citations
20.
Chen, Jeng‐Haur, David A. Stoltz, Philip H. Karp, et al.. (2010). Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia. Cell. 143(6). 911–923. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026